| Original language | English |
|---|---|
| Pages (from-to) | 2435 |
| Number of pages | 1 |
| Journal | Clinical Cancer Research |
| Volume | 26 |
| Issue number | 10 |
| DOIs | |
| State | Published - 15 May 2020 |
Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab—Letter
Daniel A. Goldstein*, Mark J. Ratain
*Corresponding author for this work
Research output: Contribution to journal › Letter › peer-review
1
Scopus
citations
